Dash Bio
PrivateLast Round
Series A
Jul 14, 2026
Est. Valuation
$17.5M
Total Funding Raised
$17.5M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Dash Bio is a biotechnology company that provides an automated bioanalysis platform using AI and robotics to accelerate clinical drug development for pharmaceutical and biotech companies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Vertical SaaS, Data Governance
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dash Bio Comparables
Compare Dash Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phylo | 82% | |
| Benchling | 77% | |
| TeselaGen Biotechnology | 77% |
Dash Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 14, 2026 | ||||
| Early Funding | Jul 23, 2025 | ||||
| Seed | Oct 24, 2024 |
Dash Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cybernetix Ventures | Early Funding |
| LifeX Ventures | Seed, Early Funding |
| LifeX Global | Early Funding |
| Oak HC/FT | Series A |
| LifeX Ventures | Seed, Early Funding |
| The Aligned Fund | Early Funding |
| Freestyle Ventures | Early Funding, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
Grew 38% QoQ, from 32 to 44 employees.
- Jul 23, 2026
Grew 45% QoQ from 29 to 42 employees.
Recent news
Latest coverage and updates
- receives_financingAug 3, 2026
dash.bio received financing of $30M in Series A on Aug 3rd '26.
Dash Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Dash Bio's valuation, stock price, and market status.
Is Dash Bio a public or private company?
Dash Bio is a private company.
What is the current stock price of Dash Bio?
Dash Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Dash Bio worth (valuation)?
Dash Bio's valuation is estimated at $17.5M based on funding round data.
Can I buy Dash Bio stock?
Dash Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Dash Bio's last funding round?
Dash Bio's most recent funding round was Series A on July 23, 2025.
Who are the main investors in Dash Bio?
Key investors in Dash Bio include The Aligned Fund, Freestyle Ventures.
Will Dash Bio IPO soon?
No public IPO plans have been announced for Dash Bio.
How can I track Dash Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dash Bio's secondary market activity and sign up for updates.